887029-63-2 Usage
Uses
Used in Pharmaceutical Industry:
2-METHOXYPROPANOHYDRAZIDE is used as an intermediate in the synthesis of various pharmaceuticals for its ability to form hydrogen bonds and participate in the production of different organic compounds.
Used in Agrochemical Industry:
2-METHOXYPROPANOHYDRAZIDE is used as a precursor in the development of agrochemicals, contributing to the creation of effective compounds for agricultural applications.
Used in Dye Industry:
2-METHOXYPROPANOHYDRAZIDE is used as a building block in the production of dyes, taking advantage of its chemical properties to create a range of colorants.
Used as a Corrosion Inhibitor:
2-METHOXYPROPANOHYDRAZIDE is used as a corrosion inhibitor in various industrial applications to protect materials from degradation and extend their lifespan.
Used for its Anti-Microbial Properties:
2-METHOXYPROPANOHYDRAZIDE is utilized for its anti-microbial properties in different settings, such as in the development of sanitizing products or in medical applications to combat infections.
Used in Flame Retardant Development:
2-METHOXYPROPANOHYDRAZIDE is studied for its potential use as a flame retardant, aiming to improve safety standards in various industries by reducing the risk of fire.
Used as a Therapeutic Agent:
2-METHOXYPROPANOHYDRAZIDE is being researched for its potential therapeutic applications in the treatment of certain diseases, highlighting its versatility and potential impact on healthcare.
Check Digit Verification of cas no
The CAS Registry Mumber 887029-63-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,0,2 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 887029-63:
(8*8)+(7*8)+(6*7)+(5*0)+(4*2)+(3*9)+(2*6)+(1*3)=212
212 % 10 = 2
So 887029-63-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H10N2O2/c1-3(8-2)4(7)6-5/h3H,5H2,1-2H3,(H,6,7)
887029-63-2Relevant academic research and scientific papers
ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS
-
Paragraph 0476, (2017/03/21)
The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.
METHODS OF TREATING PULMONARY DISEASES AND DISORDERS
-
Paragraph 0112, (2017/07/14)
The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.
COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY
-
Paragraph 0530, (2016/02/24)
The present disclosure features disclosed compounds which can increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells. The present disclosure also features methods of treating a condition associated with decreased CFTR activity or a condition associated with a dysfunction of proteostasis comprising administering to a subject an effective amount of a disclosed compound.
